Paper Title:
Differential Expression of Osteogenic Differentiation in Human Umbilical Cord Wharton’s Jelly-Derived Mesenchymal Stem Cells Treated with Demineralized Bone
  Abstract

Mesenchymal stem cells are multipotential cells capable of differentiating into osteoblasts, chondrocytes, adipocytes, tenocytes, and myoblasts. Wharton’s jelly consists of stem cells that are a rich source of primitive multipotent mesenchymal cells. Demineralized bone matrix (DBM) has been widely utilized as a biomaterial to promote new bone formation. We isolate and characterize umbilical cord Wharton’s Jelly-derived mesenchymal stem (UCMS) cells derived from Wharton’s jelly and examine the biological activity of DBM in this cell line. Osteoblast differentiation of the UCMS cells was determined using alkaline phosphatase (ALP) activity assay. To examine differential gene expression during osteogenic differentiation, total RNA was isolated from UCMS cells in the absence or presence of DBM on day7 and analyzed using osteogenesis cDNA gene array. The selected genes were verified using reverse transcriptase-polymerase chain reaction (RT-PCR) analyses. Wharton’s jelly derived cells could differentiate along an osteogenic lineage after treatment of DBM. The ALP activity assay showed that human UCMS cells could differentiate into osteogenic lineage. Gene expression of human UCMS cells treated with DBM for 7 days was analyzed by using cDNA array and RT-PCR analyses. We found that expression of RUNX2 and SMAD2 was upregulated whereas SMAD7 expression was downregulated as confirmed by RT-PCR. UCMS cells from a Wharton’s jelly of human umbilical cord could express osteogenesis genes for treatment with DBM. Wharton’s jelly from umbilical cord is a new source of mesenchymal stem cells that are readily available for application to bone tissue engineering.

  Info
Periodical
Advanced Materials Research (Volumes 55-57)
Main Theme
Edited by
Tawee Tunkasiri
Pages
697-700
DOI
10.4028/www.scientific.net/AMR.55-57.697
Citation
D. Dhitiseith, S. Honsawek, "Differential Expression of Osteogenic Differentiation in Human Umbilical Cord Wharton’s Jelly-Derived Mesenchymal Stem Cells Treated with Demineralized Bone", Advanced Materials Research, Vols. 55-57, pp. 697-700, 2008
Online since
August 2008
Export
Price
$32.00
Share

In order to see related information, you need to Login.

In order to see related information, you need to Login.

Authors: H. Kim, M. Park, Su Young Lee, Kang Yong Lee, Hyun Min Kim, S.H. Moon
Abstract:Demineralized bone matrix (DBM)-calcium phosphate cement (CPC) composites were subjected to cellular test of osteogenic potentials and...
1091
Authors: Yu Han Kim, Mi Hee Cho, In Bum Song, Hoon Hyun, Jung Won Lee, Moon Suk Kim, Seog Jin Seo, Ke Won Kang, Gil Son Khang, Sung Yun Yang, Hai Bang Lee
Abstract:In this study, we developed an injectable carrier for demineralized bone matrix (DBM) which consists of chitosan and glycerol phosphate...
177
Authors: Seog Jin Seo, Seok Beom Song, Ji Hwa Chae, Jin Young Kim, Jae Hyoung Ahn, Tae Woon Kim, Ho Chan Hwang, Jin Kim, Kwang Won Lee, Nak Heon Kang, Chong Su Cho, Ke Won Kang
Abstract:Human demineralized bone matrix (DBM) containing bone morphogenetic proteins (BMPs) is naturally biocompatible and can be remodeled by...
381
Authors: A. Rosenberg, Aliassghar Tofighi, N. Camacho, J. Chang
Abstract:A new class of osteoconductive and osteoinductive combination biomaterials composed of calcium phosphate cement (CPC), demineralized bone...
1
Authors: Zhi Yu Zhou, Li Jin Zou, Hai Sheng Li, Cody Bunger, Xue Nong Zou
Abstract:An ideal bone graft material should have osteocondutive, osteroindurctive, and osteogenic features. Scientists and doctors have been trying...
1006